Fluoroquinolones vs amoxicillin
Serious adverse events · adults aged 18 years and above with diagnosis of non‐cystic fibrosis bronchiectasis
1 finding from 1 review
- no estimate extracted2 studies · 83 participantsLow
The review found no eligible studies for this question.
It is very uncertain whether fluoroquinolones changes serious adverse events clinical criteria compared with beta‐lactams (very low certainty).